Company Filing History:
Years Active: 2004
Title: Todd J Mortler: Innovator in Cardiac Treatment Technologies
Introduction
Todd J Mortler is a renowned inventor based in Minneapolis, MN, who has made significant contributions to the field of cardiac health. With a focus on innovative solutions for heart-related conditions, Mortler has been a key figure in advancing medical technology through his patent.
Latest Patents
Todd Mortler holds a patent for "Methods and devices for improving mitral valve function." This patent addresses critical heart conditions such as dilatation and valve incompetencies, including mitral valve leakage. Specifically, the invention describes devices and methods that enhance the apposition of heart valve leaflets, ultimately improving overall valve functionality. The patented method includes placing an elongate member transversely across a heart chamber, with anchoring members securing its position. This procedure is designed to reposition papillary muscles within the heart chamber, ensuring better valve function. Additionally, the setup allows for real-time monitoring of valve performance, enabling adjustments based on collected data during the monitoring process.
Career Highlights
Mortler’s work emphasizes the intersection of innovation and healthcare, showcasing his commitment to improving patient outcomes through technology. His sole patent reflects a deep understanding of cardiac mechanics and the challenges faced in treating heart conditions.
Collaborations
Throughout his career, Todd J Mortler has collaborated with esteemed colleagues such as Richard F Schroeder and Robert M Vidlund. Their combined expertise fosters a rich environment for innovation at their company, Myocor, Inc., which focuses on developing advanced cardiovascular treatment solutions.
Conclusion
In summary, Todd J Mortler represents a vital part of the innovative landscape in cardiac health technology. His patent on improving mitral valve function reveals both his inventive spirit and dedication to creating effective medical solutions. As Mortler continues to work alongside his colleagues at Myocor, Inc., he remains poised to make further contributions that can transform the treatment of heart conditions and improve the quality of life for many patients.